These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 6741200)

  • 41. [Inhibition of H+/K+-ATPase in the parietal cell with omeprazole: a new principle of gastric acid inhibition].
    Lamers CB
    Ned Tijdschr Geneeskd; 1985 Apr; 129(15):679-82. PubMed ID: 2986019
    [No Abstract]   [Full Text] [Related]  

  • 42. Pharmacological properties of the gastric H(+)/K(+) ATPase inhibitor, AU-461.
    Cheon HG; Kim HJ; Mo HK; Lee BH; Choi J
    Pharmacology; 2000 Apr; 60(3):161-8. PubMed ID: 10754453
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Acid secretion and hormone levels after several weeks of omeprazole administration].
    Müller P; Simon B; Dammann HG; Feurle G; Huefner M; Rabe T
    Dtsch Med Wochenschr; 1983 Nov; 108(47):1816. PubMed ID: 6641533
    [No Abstract]   [Full Text] [Related]  

  • 44. Gastric acid secretion and duodenal ulcer healing during treatment with omeprazole. A Scandinavian Multicentre Study.
    Scand J Gastroenterol; 1984 Oct; 19(7):882-4. PubMed ID: 6397846
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparative pharmacodynamic study of IY-81149 versus omeprazole in patients with gastroesophageal reflux disease.
    Periclou AP; Goldwater R; Lee SM; Park DW; Kim DY; Cho KD; Boileau F; Jung WT
    Clin Pharmacol Ther; 2000 Sep; 68(3):304-11. PubMed ID: 11014412
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antisecretory effect and oral pharmacokinetics following low dose omeprazole in man.
    Howden CW; Forrest JA; Meredith PA; Reid JL
    Br J Clin Pharmacol; 1985 Aug; 20(2):137-9. PubMed ID: 3929808
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gastric acid antisecretory effect of two different dosage forms of omeprazole during prolonged oral treatment in the gastric fistula dog.
    Larsson H; Mattsson H; Carlsson E
    Scand J Gastroenterol; 1988 Oct; 23(8):1013-9. PubMed ID: 3201125
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oral pharmacokinetics of omeprazole.
    Howden CW; Meredith PA; Forrest JA; Reid JL
    Eur J Clin Pharmacol; 1984; 26(5):641-3. PubMed ID: 6468483
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Omeprazole: effects on oxidative drug metabolism.
    Henry DA; Somerville KW; Kitchingman G; Langman MJ
    Br J Clin Pharmacol; 1984 Aug; 18(2):195-200. PubMed ID: 6487457
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structure activity relationships of substituted benzimidazoles.
    Brändström A; Lindberg P; Junggren U
    Scand J Gastroenterol Suppl; 1985; 108():15-22. PubMed ID: 3858974
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety of acid-suppressing drugs.
    Smallwood RA; Berlin RG; Castagnoli N; Festen HP; Hawkey CJ; Lam SK; Langman MJ; Lundborg P; Parkinson A
    Dig Dis Sci; 1995 Feb; 40(2 Suppl):63S-80S. PubMed ID: 7859585
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of single and repeated doses of oral omeprazole on gastric acid and pepsin secretion and fasting serum gastrin and serum pepsinogen I levels.
    Festen HP; Tuynman HA; Défize J; Pals G; Frants RR; Straub JP; Meuwissen SG
    Dig Dis Sci; 1986 Jun; 31(6):561-6. PubMed ID: 3086061
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.
    Clissold SP; Campoli-Richards DM
    Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [4 weeks' administration of omeprazole: effect on acid behavior and basal hormone levels].
    Müller P; Seitz HK; Simon B; Dammann HG; Feurle G; Huefner M; Lichtwald K; Schmidt-Gayk H
    Z Gastroenterol; 1984 May; 22(5):236-40. PubMed ID: 6741200
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Behavior of acid secretion under the long-term daily administration of omeprazol].
    Dammann HG; Müller P; Seitz HK; Simon B
    Schweiz Med Wochenschr; 1983 Jun; 113(24):895-8. PubMed ID: 6348940
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of omeprazole on insulin induced gastric secretion in man.
    Utley RJ; Wright R; Beastall GH; Carter DC
    Scott Med J; 1985 Apr; 30(2):96-100. PubMed ID: 3892679
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.